All filters
Videos
Longitudinal Study on Insulin Resistance and Metabolic Syndrome in Children with Perinatal HIV Infection and HIV Exposed Uninfected Children in South Africa - Claire Davies, South Africa
Presented at:
International Workshop on HIV Pediatrics 2021
Videos
Dolutegravir and Weight Gain to Adolescents Living with HIV at Baylor Mwanza-Tanzania - Esther Masunga, Tanzania
Presented at:
International Workshop on HIV Pediatrics 2021
Videos
Weight Gain in Children and Adolescents on Dolutegravir vs Standard-of-Care in the ODYSSEY Trial - Hilda Angela Mujuru, Zimbabwe
Presented at:
International Workshop on HIV Pediatrics 2021
Videos
LATE BREAKER - Dolutegravir-Based Art is Superior to Standard of Care in Young Children Living With HIV - Pauline Amuge, Uganda
Presented at:
International Workshop on HIV Pediatrics 2021
Videos
Clinical Impact and Cost-Effectiveness of Viral Load Testing (VLT) to Inform the Transition to Pediatric Dolutegravir (DTG) in Antiretroviral Therapy (ART)-Experienced Children With HIV in South Africa - Isaac Ravi Brenner, United States
Presented at:
International Workshop on HIV Pediatrics 2021
Videos
Pharmacokinetics, Safety and Acceptability of a Single Dose of Abacavir/Lamivudine/Lopinavir/Ritonavir (4-In-1) Fixed-Dose Granule Formulation In Neonates: PETITE Study - Tim Cressey, Thailand
Presented at:
International Workshop on HIV Pediatrics 2021
Videos
Long-Term Safety & Efficacy of Elvitegravir/Cobicistat/Emtricitabine/ Tenofovir Alafenamide Fumarate (E/C/F/TAF) Single-Tablet Regimen In Children and Adolescents Living With HIV - Suvaporn Anugulruengkitt, Thailand
Presented at:
International Workshop on HIV Pediatrics 2021
Videos
Pharmacokinetics and Safety of Dispersible- and Immediate-Release FDC Dolutegravir/Abacavir/Lamivudine in Children with HIV Weighing ≥14 Kg: Preliminary Results from IMPAACT 2019 - Kristina Brooks, United States
Presented at:
International Workshop on HIV Pediatrics 2021
Videos
B/F/Taf in Virologically Suppressed Adolescents and Children: Two- Year Outcomes in 6 to <18 Year Olds And Six-Month Outcomes in Toddlers - Eva Natukunda, Uganda
Presented at:
International Workshop on HIV Pediatrics 2021
Videos
Once-Daily Integrase Inhibitor (Insti) With Boosted Darunavir is Non- Inferior to Standard of Care in Virogically Suppressed Children, Week 48 Results of the Smile PENTA-17 Trial - Alexandra Compagnucci, France
Presented at:
International Workshop on HIV Pediatrics 2021
Videos
Pediatric HIV Treatment and Prevention: What’s New for 2021 - Martina Penazzato, MD, MSc, PhD
Presented at:
International Workshop on HIV Pediatrics 2021
Videos
The HIV Epidemic in Infants, Children, Adolescents and Women Today – 2021 UNAIDS Update - Mary Mahy, ScD, MHSc
Presented at:
International Workshop on HIV Pediatrics 2021
Videos
ViiV Symposium - Children and Challenges they Face... Our Calling: Optimizing Care in Pediatric HIV Treatment - HIV Pediatrics 2021
Presented at:
International Workshop on HIV Pediatrics 2021
Videos
On Demand Youth Panel - HIV Pediatrics 2021
Presented at:
International Workshop on HIV Pediatrics 2021
Videos
Dual Therapy with Dolutegravir and Lamivudine | Pedro Cahn, MD, PhD (Portuguese)
Presented at:
São Paulo HIV Clinical Forum 2021
Videos
Dual Therapy with Dolutegravir and Lamivudine | Pedro Cahn, MD, PhD (Original)
Presented at:
São Paulo HIV Clinical Forum 2021
Videos
The Importance of Drug-Drug Interactions in ART | David Back, PhD (Portuguese)
Presented at:
São Paulo HIV Clinical Forum 2021
Videos
The Importance of Drug-Drug Interactions in ART | David Back, PhD (Original)
Presented at:
São Paulo HIV Clinical Forum 2021
Videos
Integrase Inhibitors and Pregnancy | Claudia Cortes, MD
Presented at:
São Paulo HIV Clinical Forum 2021
Videos
Antiretroviral Treatment and Tuberculosis | Beatriz Grinsztejn, MD, PhD (Portuguese)
Presented at:
São Paulo HIV Clinical Forum 2021